What type of study is this?

This is a Cross-Sectional Study study (also classified as: Quantitative Study, Experimental Study).

September 16, 2025Cancer ReportsOpen Access

Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective

View Full Paper

Ask AI

Bookmark

Authors

This study identifies tumor antigens and four immune subtypes in hepatocellular carcinoma, suggesting new vaccine strategies.

Two potential tumor antigens, ZNF831 and SYNE1, correlate with antigen presenting cells and prognostic effects.
The study analyzed data from 159 HCC patients across genome, transcriptome, proteome, and phosphoproteome.
Four immune subtypes were identified, showcasing distinct molecular features including immune checkpoints and tumor antigen expression.
Insights from this research may enhance the development of targeted cancer vaccines and improve precision medicine for HCC.

Wang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 16, 2025Cancer ReportsOpen Access

View Full Paper

Ask AI

Bookmark

Authors

This study identifies tumor antigens and four immune subtypes in hepatocellular carcinoma, suggesting new vaccine strategies.

Two potential tumor antigens, ZNF831 and SYNE1, correlate with antigen presenting cells and prognostic effects.
The study analyzed data from 159 HCC patients across genome, transcriptome, proteome, and phosphoproteome.
Four immune subtypes were identified, showcasing distinct molecular features including immune checkpoints and tumor antigen expression.
Insights from this research may enhance the development of targeted cancer vaccines and improve precision medicine for HCC.

Wang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark